Please login to the form below

Not currently logged in
Email:
Password:

Patent

This page shows the latest Patent news and features for those working in and with pharma, biotech and healthcare.

Pfizer builds gap between pharma and consumer health units

Pfizer builds gap between pharma and consumer health units

Pfizer CEO described the move as a “natural evolution”for the group as it looks to life beyond 2020 – after which it will have dealt with most of its ‘patent cliff’–

Latest news

More from news
Approximately 84 fully matching, plus 1,041 partially matching documents found.

Latest Intelligence

  • Can new data aggregators shift the balance of power away from pharma? Can new data aggregators shift the balance of power away from pharma?

    However, it was only 20 years ago that several genomics companies, led by Human Genome Sciences Inc, thought they could secure a monopoly position over unprecedented drug targets by filing patents

  • Mylan sees the UK paving the way for an insulin game changer Mylan sees the UK paving the way for an insulin game changer

    The dream is that, on Day One when the product loses its patent, 100% of the patients use the biosimilar and the opportunity has been optimised. ... biosimilar and the promise of Mylan’s pipeline, which is fuelled by an annual Research &Development

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    No new classes of antibiotics have been introduced for more than 30 years and antibiotic patent applications worldwide.

  • Deal Watch January 2018

    Licence. 217. Teva Pharmaceuticals/ Alder Biopharmaceuticals. Patents covering anti-calcitonin gene-related peptide (CGRP) antibodies and methods - eptinezumab (p3). † ... Patent settlement, non-exclusive licence. 200. Mallinckrodt/Baxter International.

  • Drug R&D

    Healthcare terms - Drug R&D.

More from intelligence
Approximately 2 fully matching, plus 103 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest from PMHub

  • Random42 appoints Bill Collis as Chairman

    Bill's leadership skills earned him an Ernst &Young Entrepreneur Of The Year award in 2012 and he is also the proud owner of numerous patents, a major feature movie credit,

  • Indians scalp cowboys in patent war

    Indians scalp cowboys in patent war. An unlikely treaty between global pharma and native Americans. ... At the same time, imaginative patent lawyers will be racking their brains to exploit new opportunities.

  • Global Corporate Divestment Study

    Expiring patents along with regulatory and reimbursement changes were significant divestment drivers.

  • Biosimilars: Getting the flock to market

    Patents were protected and intellectual property was defended. This is hardly surprising, as billions are at stake - Remicade alone earned Johnson &Johnson over $6bn a year, while Humira is responsible for ... Humira alone has more than a dozen

  • Tackling biosimilars – how to handle the threat to Pharma brands

    Representing millions in lost profits, the Patent Cliff was (and continues to be) a major challenge for Pharma brands. ... Their product, a treatment in the gastroenterology therapy area, had recently come off patent and a biosimilar was about to launch.

More from PMHub
Approximately 2 fully matching, plus 37 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics